LORCAN MCKILLOP: Open Payments
NPI 1326636622 · LONG ISLAND CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,000 in 109 payments from 23 companies in 2025. Trend: 2023 $2,540 · 2024 $1,976 · 2025 $3,000
Food & beverage: $3,000
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $568 |
| Mannkind Corporation | 7 | $329 |
| Xeris Pharmaceuticals, Inc. | 17 | $286 |
| Lilly USA, LLC | 12 | $276 |
| Abbott Laboratories | 4 | $218 |
| Ascendis Pharma Endocrinology Inc | 4 | $201 |
| Insulet Corporation | 5 | $153 |
| Madrigal Pharmaceuticals | 6 | $152 |
| TOLMAR, INC. | 6 | $131 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $125 |
Products named: Ozempic, AFREZZA, FREESTYLE LIBRE 3, MOUNJARO, Yorvipath, JARDIANCE, Omnipod, REZDIFFRA.
Industry payments across NY — which companies pay providers there.
